1 |
Aceclofenac, Paracetamol |
Aceclofenac |
IP |
100mg |
|
& Serratiopeptidase Tablets. |
Paracetamol |
IP |
325mg |
|
|
Serratiopeptidase |
IP |
15mg |
|
|
(As enteric coated) |
|
|
|
|
(eq. to enzyme activity 30000 Units) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
2 |
Pregabalin, Nortriptyline & |
Composition: Each film coated tablet contains: |
|
|
|
Mecobalamin Tablets. |
Pregabalin |
IP |
75mg |
|
|
Nortriptyline Hydrochloride |
IP |
|
|
|
Eq. to Nortriptyline |
|
10mg |
|
|
Mecobalamin |
IP |
1500mcg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
3 |
Methylcobalamin and |
Composition: Each film coated tablet contains: |
|
|
|
Gabapentin Tablets |
Methylcobalamin |
IP |
1500mcg |
|
|
Gabapentin |
IP |
600mg |
|
|
(As sustained release form) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
4 |
Calcium citrate, Vitamin D3, |
Composition: Each uncoated tablet contains: |
|
|
|
Magnesium Hydroxide and |
Calcium citrate |
USP |
1000mg |
|
Zinc sulphate Tablets. |
Vitamin D3 |
IP |
200 IU |
|
|
Magnesium Hydroxide |
IP |
100mg |
|
|
Zinc sulphate monohydrate |
IP |
4mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Composition: Each film coated tablet contains: |
P. Ref. |
Units |
5 |
Calcium and Vitamin D3 Tablets. IP |
Calcium carbonate |
IP |
1.250gm |
|
|
(1.25gm of calcium carbonate from an organic source (Oyster shell) eq. to elemental Calcium 500mg) |
|
|
|
|
Vitamin D3 |
IP |
250 IU |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
6 |
Ketorolac Tromethamine |
Ketorolac Tromethamine |
IP |
10mg |
|
Tablets IP |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
7 |
Ivermectin Tablets IP |
Composition: Each uncoated dispersible tablet contains: |
|
|
|
|
Ivermectin |
IP |
12mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
8 |
Ivermectin Tablets IP |
Composition: Each uncoated dispersible tablet contains: |
|
|
|
|
Ivermectin |
IP |
6mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
9 |
Esomeprazole Tablets IP |
Composition: Each enteric coated tablet contains: |
|
|
|
|
Esomeprazole Magnesium Trihydrate |
IP |
|
|
|
Eq. to Esomeprazole |
|
40mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
10 |
Esomeprazole Tablets IP |
Composition: Each enteric coated tablet contains: |
|
|
|
|
Esomeprazole Magnesium Trihydrate |
IP |
|
|
|
Eq. to Esomeprazole |
|
20mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Fexofenadine Hydrochloride |
Composition: Each film coated tablet contains: |
|
|
|
Tablets IP |
Fexofenadine Hydrochloride |
IP |
120mg |
11 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Fexofenadine Hydrochloride |
Composition: Each film coated tablet contains: |
|
|
|
Tablets IP |
Fexofenadine Hydrochloride |
IP |
180mg |
12 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Febuxostat Tablets |
Composition: Each film coated tablet contains: |
|
|
|
|
Febuxostat |
|
80mg |
13 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Febuxostat Tablets |
Composition: Each film coated tablet contains: |
|
|
|
|
Febuxostat |
|
40mg |
14 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Rifaximin Tablets |
Composition: Each film coated tablet contains: |
|
|
15 |
|
Rifaximin |
BP |
550mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Methylprednisolone Tablets IP |
Composition: Each film coated tablet contains: |
|
|
|
|
Methylprednisolone |
IP |
4mg |
16 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Methylprednisolone Tablets IP |
Composition: Each film coated tablet contains: |
|
|
|
|
Methylprednisolone |
IP |
8mg |
17 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Methylprednisolone Tablets IP |
Composition: Each film coated tablet contains: |
|
|
18 |
|
Methylprednisolone |
IP |
16mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Etoricoxib Tablet IP |
Composition: Each film coated tablet contains: |
|
|
19 |
|
Etoricoxib |
IP |
90mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Etoricoxib Tablet IP |
Composition: Each film coated tablet contains: |
|
|
20 |
|
Etoricoxib |
|
120mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Drotaverine Hydrochloride |
Composition: Each film coated tablet contains: |
|
|
|
Tablets IP |
Drotaverine Hydrochloride |
IP |
80mg |
21 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Levocetirizine Hydrochloride |
Composition: Each film coated tablet contains: |
|
|
|
Tablets IP |
Levocetirizine Hydrochloride |
IP |
5mg |
22 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Fluconazole Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
|
|
Fluconazole |
IP |
150mg |
23 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Fluconazole Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
24 |
|
Fluconazole |
IP |
200mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Cetirizine Hydrochloride |
Composition: Each uncoated tablet contains: |
|
|
25 |
Tablets IP |
Cetirizine Hydrochloride |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Terbinafine Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
|
|
Terbinafine Hydrochloride |
IP |
|
26 |
|
Eq. to Terbinafine |
|
250mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Etizolam Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
27 |
|
Etizolam |
IP |
0.25mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ursodeoxycholic acid Tablets IP |
Composition: Each film coated tablet contains: |
|
|
28 |
|
Ursodeoxycholic acid |
IP |
150mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ursodeoxycholic acid Tablets IP |
Composition: Each film coated tablet contains: |
|
|
29 |
|
Ursodeoxycholic acid |
IP |
300mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Albendazole Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
30 |
|
Albendazole |
IP |
400mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Terbinafine Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
31 |
|
Terbinafine Hydrochloride |
IP |
250mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Rabeprazole & Domperidone |
Composition: Each enteric coated tablet contains: |
|
|
32 |
Tablets |
Rabeprazole sodium |
IP |
20mg |
|
|
Domperidone |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Pantoprazole & Domperidone |
Composition: Each enteric coated tablet contains: |
|
|
|
Tablets |
Pantoprazole sodium sesquehydrate |
IP |
|
|
|
Eq. to Pantoprazole |
|
40mg |
33 |
|
Domperidone |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Serratiopeptidase and Diclofenac |
Composition: Each enteric coated tablet contains: |
|
|
|
Sodium Tablets |
Diclofenac Sodium |
IP |
50mg |
|
|
Serratiopeptidase |
IP |
10mg |
34 |
|
(eq. to enzymatic activity 20000 Units) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ornidazole and Levofloxacin |
Composition: Each film coated tablet contains: |
|
|
|
Tablets |
Ornidazole |
IP |
500mg |
35 |
|
Levofloxacin Hemihydrate |
IP |
|
|
|
Eq. to Levofloxacin |
|
250mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Mefenamic acid & Dicyclomine |
Composition: Each uncoated tablet contains: |
|
|
36 |
Hydrochloride Tablets IP |
Mefenamic acid |
IP |
250mg |
|
|
Dicyclomine Hydrochloride |
IP |
80mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Amlodipine & Metoprolol |
Composition: Each film coated tablet contains: |
|
|
|
Succinate Tablets |
Amlodipine Besylate |
IP |
|
|
|
eq. to Amlodipine |
|
5mg |
37 |
|
Metoprolol Succinate |
IP |
|
|
|
Eq. to Metoprolol Tartrate |
|
50mg |
|
|
(As extended Release) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Gabapentin & Nortriptyline |
Composition: Each film coated tablet contains: |
|
|
|
Hydrochloride Tablets |
Gabapentin |
IP |
400mg |
38 |
|
Nortriptyline Hydrochloride |
IP |
|
|
|
Eq. to Nortriptyline |
|
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Loprnoxicam & Paracetamol |
Composition: Each film coated tablet contains: |
|
|
|
Tablets |
Loprnoxicam |
|
8mg |
39 |
|
Paracetamol |
IP |
325mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Etodolac & Thiocolchicoside |
Composition: Each film coated tablet contains: |
|
|
40 |
Tablets |
Etodolac |
IP |
60mg |
|
|
Thiocolchicoside |
IP |
4mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Etodolac & Thiocolchicoside |
Composition: Each film coated tablet contains: |
|
|
45 |
Tablets |
Etodolac |
IP |
400mg |
|
|
Thiocolchicoside |
IP |
4mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Glucosamine, Diacerein and |
Composition: Each film coated tablet contains: |
|
|
|
Methylsulfonylmethane Tablets |
Glucosamine sulfate potassium chloride |
USP |
750mg |
46 |
|
Diacerein |
IP |
50mg |
|
|
Methylsulfonylmethane |
USP |
250mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Tranexamic acid & Mefenamic |
Composition: Each film coated tablet contains: |
|
|
|
Acid Tablets |
Tranexamic acid |
IP |
500mg |
47 |
|
Mefenamic acid |
IP |
250mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Montelukast sodium and |
Composition: Each film coated tablet contains: |
|
|
|
Levocetirizine HCl Tablets |
Montelukast sodium |
IP |
|
48 |
|
Eq. to Montelukast |
|
10mg |
|
|
Levocetirizine Dihydrochloride |
IP |
5mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Aceclofenac, Paracetamol and |
Composition: Each film coated tablet contains: |
|
|
|
Thiocolchicoside Tablets |
Aceclofenac |
IP |
100mg |
49 |
|
Paracetamol |
IP |
325mg |
|
|
Thiocolchicoside |
IP |
4mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Citicolin & Piracetam Tablets |
Composition: Each film coated tablet contains: |
|
|
|
|
Citicolin Sodium |
IP |
|
50 |
|
Eq. to Citicolin |
|
500mg |
|
|
Piracetam |
IP |
800mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Montelukast sodium and |
Composition: Each film coated tablet contains: |
|
|
|
Fexofenadine HCl Tablets |
Montelukast sodium |
IP |
|
51 |
|
Eq. to Montelukast |
|
10mg |
|
|
Fexofenadine hydrochloride |
IP |
120mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (SR), |
Composition: Each uncoated bilayered tablet contains: |
|
|
|
Glimepiride & Voglibose |
Metformin Hydrochloride |
IP |
500mg |
|
Tablets |
(As Sustained Release Form) |
|
|
52 |
|
Glimepiride |
IP |
1mg |
|
|
Voglibose |
IP |
0.2mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (SR), |
Composition: Each uncoated bilayered tablet contains: |
|
|
|
Glimepiride & Voglibose |
Metformin Hydrochloride |
IP |
500mg |
53 |
Tablets |
(As Sustained Release) |
|
|
|
|
Glimepiride |
IP |
1mg |
|
|
Voglibose |
IP |
0.3mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol and Diclofenac |
Composition: Each uncoated tablet contains: |
|
|
|
Potassium Tablets |
Paracetamol |
IP |
325mg |
54 |
|
Diclofenac Potassium |
BP |
50mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Montelukast sodium, Ambroxol |
Composition: Each uncoated bilayered tablet contains: |
|
|
|
HCl (SR) & Levocetirizine HCl |
Montelukast sodium |
IP |
|
|
Tablets |
Eq. to Montelukast |
|
10mg |
|
|
Levocetirizine Dihydrochloride |
IP |
5mg |
55 |
|
Ambroxol Hydrochloride |
IP |
75mg |
|
|
(As Sustained Release) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (ER), |
Composition: Each uncoated tablet contains: |
|
|
|
Glimepiride & Pioglitazone HCl |
Metformin Hydrochloride |
IP |
500mg |
|
Tablets |
(As Extended Release) |
|
|
56 |
|
Glimepiride |
IP |
1mg |
|
|
Pioglitazone Hydrochloride |
IP |
|
|
|
Eq. to Pioglitazone |
|
15mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Albendazole & Ivermectin Tab. |
Composition: Each uncoated tablet contains: |
|
|
|
|
Albendazole |
IP |
400mg |
57 |
|
Ivermectin |
IP |
6mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (SR), |
Composition: Each uncoated bilayered tablet contains: |
|
|
|
Gliclazide (SR) & Pioglitazone HCl Tablets |
Metformin Hydrochloride |
IP |
500mg |
58 |
|
(As Sustained Release) |
|
|
|
|
Gliclazide |
IP |
30mg |
|
|
(As Sustained Release) |
|
|
|
|
Pioglitazone Hydrochloride |
IP |
|
|
|
Eq. to Pioglitazone |
|
15mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (PR) |
Composition: Each uncoated tablet contains: |
|
|
|
& Glimepiride Tablets IP |
Metformin Hydrochloride |
IP |
500mg |
|
|
(As Prolonged Release) |
|
|
59 |
|
Glimepiride |
IP |
2mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (PR) |
Composition: Each uncoated tablet contains: |
|
|
|
& Glimepiride Tablets IP |
Metformin Hydrochloride |
IP |
500mg |
|
|
(As Prolonged Release) |
|
|
60 |
|
Glimepiride |
IP |
1mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Amlodipine &Atenolol Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
|
|
Amlodipine Besylate |
IP |
|
|
|
eq. to Amlodipine |
|
5mg |
61 |
|
Atenolol |
IP |
50mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Etoricoxib & Paracetamol Tab. |
Composition: Each uncoated tablet contains: |
|
|
|
|
Etoricoxib |
IP |
60mg |
62 |
|
Paracetamol |
IP |
325mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Tramadol HCl, Paracetamol & |
Composition: Each uncoated tablet contains: |
|
|
|
Domperidone Tablets |
Tramadol Hydrochloride |
IP |
50mg |
63 |
|
Paracetamol |
IP |
325mg |
|
|
Domperidone |
IP |
15mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Cetirizine hydrochloride, |
Composition: Each uncoated tablet contains: |
|
|
|
Phenylephrine hydrochloride & |
Cetirizine hydrochloride |
IP |
5mg |
64 |
Paracetamol Tablets |
Phenylephrine hydrochloride |
IP |
5mg |
|
|
Paracetamol |
IP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Aceclofenac, Paracetamol & |
Composition: Each film-coated tablet contains: |
|
|
|
Trypsin-Chymotrypsin Tablets |
Paracetamol |
IP |
325mg |
65 |
|
Aceclofenac |
IP |
100mg |
|
|
Trypsin-Chymotrypsin |
|
50000 AU |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Deflazacort Tablets |
Composition: Each uncoated tablet contains: |
|
|
|
|
Deflazacort |
|
6mg |
66 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Deflazacort Tablets |
Composition: Each uncoated tablet contains: |
|
|
67 |
|
Deflazacort |
|
30mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Deflazacort Tablets |
Composition: Each uncoated tablet contains: |
|
|
|
|
Deflazacort |
|
12mg |
68 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Pantoprazole & Domperidone |
Composition: Each enteric-coated tablet contains: |
|
|
|
Tablets |
Pantoprazole sodium sesquehydrate |
IP |
|
69 |
|
Eq. to Pantoprazole |
|
40mg |
|
|
Domperidone |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Rabeprazole & Domperidone |
Composition: Each enteric-coated tablet contains: |
|
|
70 |
Tablets |
Rabeprazole Sodium |
IP |
20mg |
|
|
Domperidone |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Aceclofenac & Thiocolchicoside |
Composition: Each film-coated tablet contains: |
|
|
|
Tablets |
Aceclofenac |
IP |
100mg |
71 |
|
Thiocolchicoside |
IP |
4mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol Tablets IP 650mg |
Composition: Each uncoated tablet contains: |
|
|
|
|
Paracetamol |
IP |
650mg |
72 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
L-Carnitine L-Tatrate, Folic acid |
Composition: Each film-coated tablet contains: |
|
|
|
& Methylcobalamin Tablets |
L-Carnitine L-Tatrate |
|
500mg |
73 |
|
Folic acid |
IP |
1.5mg |
|
|
Methylcobalamin |
IP |
1500mcg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Gabapentin & Methylcobalamin |
Composition: Each film-coated tablet contains: |
|
|
|
Tablets |
Gabapentin |
IP |
300mg |
74 |
|
Methylcobalamin |
IP |
500mcg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol, Phenylephrine HCl, |
Composition: Each un-coated tablet contains: |
|
|
|
Caffeine anhydrous and |
Paracetamol |
IP |
500mg |
|
Diphenhydramine HCl Tablets |
Caffeine anhydrous |
IP |
30mg |
75 |
|
Phenylephrine Hydrochloride |
IP |
5mg |
|
|
Diphenhydramine Hydrochloride |
IP |
25mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Doxylamine Succinate, Pyridoxine HCl & Folic acid Tablets |
Composition: Each enteric coated tablet contains: |
|
|
|
|
Doxylamine Succinate |
USP |
10mg |
|
|
Pyridoxine HCl |
IP |
10mg |
76 |
|
Folic acid |
IP |
2.5mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Pancreatin & Activated |
Composition: Each enteric coated tablet contains: |
|
|
77 |
Dimethicone Tablets |
Pancreatin |
IP |
170mg |
|
|
Activated Dimethicone |
IP |
80mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol, Diclofenac |
Composition: Each film coated tablet contains: |
|
|
|
potassium & Serratiopeptidase |
Paracetamol |
IP |
325mg |
|
Tablets |
Diclofenac potassium |
IP |
50mg |
78 |
|
Serratiopeptidase |
IP |
10mg |
|
|
(eq. to 20000 enzymatic Units) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Atorvastatin Tablets IP |
Composition: Each film coated tablet contains: |
|
|
|
|
Atorvastatin calcium |
IP |
|
79 |
|
eq. to Atorvastatin |
|
40mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol, Diclofenac sodium and Serratiopeptidase Tablets |
Composition: Each film-coated tablet contains: |
|
|
|
|
Paracetamol |
IP |
325mg |
|
|
Diclofenac Sodium |
IP |
50mg |
80 |
|
Serratiopeptidase |
IP |
15mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Hydroxychloroquine sulphate |
Composition: Each film-coated tablet contains: |
|
|
|
Tablets IP |
Hydroxychloroquine sulphate |
IP |
300mg |
81 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Azithromycin & Lactic acid |
Composition: Each film-coated tablet contains: |
|
|
|
Bacillus Tablets |
Azithromycin Dihydrate |
IP |
|
82 |
|
eq. to Azithromycin |
|
500mg |
|
|
Lactic acid bacillus |
|
60 million spo |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ofloxacin & Ornidazole Tablet IP |
Composition: Each film-coated tablet contains: |
|
|
|
|
Ofloxacin |
IP |
200mg |
83 |
|
Ornidazole |
IP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ofloxacin, Ornidazole & Lactic |
Composition: Each film-coated tablet contains: |
|
|
|
Acid bacillus Tablets |
Ofloxacin |
IP |
200mg |
84 |
|
Ornidazole |
IP |
500mg |
|
|
Lactic acid bacillus |
|
5 billion spore |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Tadalafil Tablets IP |
Composition: Each film-coated tablet contains: |
|
|
85 |
|
Tadalafil |
IP |
5mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Levofloxacin & Ornidazole |
Composition: Each film-coated tablet contains: |
|
|
|
Tablets |
Levofloxacin Hemihydrate |
IP |
|
86 |
|
eq. to Levofloxacin |
|
250mg |
|
|
Ornidazole |
IP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Cilnidipine Tablets IP |
Composition: Each film-coated tablet contains: |
|
|
87 |
|
Cilnidipine |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Gabapentin Tablets IP |
Composition: Each film-coated tablet contains: |
|
|
88 |
|
Gabapentin |
IP |
300mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Calcium citrate, Methylcobalamin, |
Composition: Each film-coated tablet contains: |
|
|
|
Vit-D3, L-Methylfolate & |
Calcium citrate |
USP |
1250mg |
|
Pyridoxal-5-Phosphate Tablets |
Vitamin-D3 |
IP |
2000 IU |
89 |
|
Methylcobalamin |
IP |
1500mcg |
|
|
L-Methylfolate |
|
1mg |
|
|
Pyridoxal-5-Phosphate |
|
20mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Calcium citrate, Calcitriol & |
Composition: Each film-coated tablet contains: |
|
|
|
Vitamin K2-7 Tablets |
Calcium citrate |
USP |
1200mg |
90 |
|
Vitamin K2-7 |
|
50mcg |
|
|
Calcitriol |
IP |
0.25mcg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Piracetam Tablets |
Composition: Each film-coated tablet contains: |
|
|
91 |
|
Piracetam |
IP |
800mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Levocetirizine Dihydrochloride |
Composition: Each film-coated tablet contains: |
|
|
92 |
& Ambroxol HCl Tablets |
Levocetirizine Dihydrochloride |
IP |
5mg |
|
|
Ambroxol Hydrochloride |
IP |
30mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ciprofloxacin Tablets IP |
Composition: Each film-coated tablet contains: |
|
|
93 |
|
Ciprofloxacin Hydrochloride |
IP |
|
|
|
eq. to Ciprofloxacin |
|
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol, Aceclofenac & |
Composition: Each Un-coated tablet contains: |
|
|
94 |
Chlorzoxazone Tablets |
Paracetamol |
IP |
325mg |
|
|
Aceclofenac |
IP |
100mg |
|
|
Chlorzoxazone |
USP |
250mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Atorvastatin Tablets IP |
Composition: Each film coated tablet contains: |
|
|
|
|
Atorvastatin calcium |
IP |
|
95 |
|
eq. to Atorvastatin |
|
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
S-Adenosyl-L-Methionine |
Composition: Each enteric coated tablet contains: |
|
|
96 |
Disulfate Tablets |
S-Adenosyl-L-Methionine Disulfate |
|
400mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Aspirin Tablets IP |
Composition: Each Un-coated tablet contains: |
|
|
97 |
|
Aspirin |
IP |
300mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol, Diclofenac Sodium |
Composition: Each Un-coated tablet contains: |
|
|
|
& Chlorzoxazone Tablets |
Paracetamol |
IP |
325mg |
98 |
|
Diclofenac Sodium |
IP |
50mg |
|
|
Chlorzoxazone |
USP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol & Nimesulide |
Composition: Each Un-coated tablet contains: |
|
|
|
Tablets |
Paracetamol |
IP |
325mg |
99 |
|
Nimesulide |
BP |
100mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Gabapentin, Methylcobalamin |
Composition: Each film coated tablet contains: |
|
|
|
& Alpha Lipoic Acid Tablets |
Gabapentin |
IP |
100mg |
100 |
|
Methylcobalamin |
IP |
500mcg |
|
|
Alpha Lipoic Acid |
IP |
100mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Flunarizine & Domperidone |
Composition: Each Un-coated tablet contains: |
|
|
|
Tablets |
Flunarizine Dihydrochloride |
IP |
|
101 |
|
eq. Flunarizine |
|
5mg |
|
|
Domperidone |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Aceclofenac & Paracetamol |
Composition: Each film coated tablet contains: |
|
|
|
Tablets |
Aceclofenac |
IP |
100mg |
102 |
|
Paracetamol |
IP |
325mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol & Domperidone |
Composition: Each Un-coated tablet contains: |
|
|
|
Tablets |
Paracetamol |
IP |
650mg |
103 |
|
Domperidone |
IP |
20mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin HCl (ER), |
Each Un-coated bilayered tablet contains: |
|
|
|
Glimepiride & Voglibose Tablets |
Metformin Hydrochloride |
IP |
500mg |
104 |
|
(As extended release form) |
|
|
|
|
Glimepiride |
IP |
2mg |
|
|
Voglibose |
IP |
0.2mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Fexofenadine HCl, Montelukast |
Each Un-coated bilayered tablet contains: |
|
|
|
Sodium & Acebrophylline (SR) |
Fexofenadine Hydrochloride |
IP |
120mg |
105 |
Tablets |
Montelukast Sodium |
IP |
|
|
|
Eq. to Montelukast |
|
10mg |
|
|
Acebrophylline |
|
200mg |
|
|
(As Sustained Release form) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Nimesulide, Phenylephrine HCl, |
Composition: Each Un-coated tablet contains: |
|
|
|
Cetirizine HCl & Caffeine Tab. |
Nimesulide |
BP |
100mg |
106 |
|
Phenylephrine Hydrochloride |
IP |
10mg |
|
|
Cetirizine Hydrochloride |
IP |
5mg |
|
|
Caffeine |
IP |
30mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Nimesulide, Phenylephrine HCl, |
Composition: Each Un-coated tablet contains: |
|
|
|
Paracetamol & Caffeine Tab. |
Paracetamol |
IP |
325mg |
107 |
|
Nimesulide |
BP |
100mg |
|
|
Phenylephrine Hydrochloride |
IP |
10mg |
|
|
Caffeine |
IP |
25mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol, Phenylephrine HCl, |
Composition: Each Un-coated tablet contains: |
|
|
|
Cetirizine HCl, Guaiphenesin & |
Paracetamol |
IP |
325mg |
|
Ambroxol HCl Tablets |
Phenylephrine Hydrochloride |
IP |
5mg |
108 |
|
Cetirizine Hydrochloride |
IP |
5mg |
|
|
Guaiphenesin |
IP |
50mg |
|
|
Ambroxol Hydrochloride |
IP |
15mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Albendazole & Ivermectin Tab. |
Composition: Each film coated tablet contains: |
|
|
|
|
Albendazole |
IP |
400mg |
109 |
|
Ivermectin |
IP |
6mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Fluconazole Dispersible Tablets |
Each un-coated dispersible tablet contains: |
|
|
110 |
|
Fluconazole |
IP |
50mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Pioglitazone HCl & Glimepiride |
Composition: Each film coated tablet contains: |
|
|
|
Tablets |
Pioglitazone Hydrochloride |
IP |
|
111 |
|
eq. to Pioglitazone |
|
15mg |
|
|
Glimepiride |
IP |
2mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Drotaverine HCl & Paracetamol |
Composition: Each uncoated tablet contains: |
|
|
|
Tablets |
Drotaverine Hydrochloride |
IP |
80mg |
112 |
|
Paracetamol |
IP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Tadalafil Tablets IP |
Composition: Each film coated tablet contains: |
|
|
113 |
|
Tadalafil |
IP |
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ciprofloxacin & Ornidazole |
Composition: Each film coated tablet contains: |
|
|
|
Tablets |
Ciprofloxacin Hydrochloride |
IP |
|
114 |
|
eq. to Ciprofloxacin |
|
500mg |
|
|
Ornidazole |
IP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Calcium carbonate & Vitamin |
Composition: Each film coated tablet contains: |
|
|
|
D3 Tablets IP |
Calcium carbonate |
IP |
|
114 |
|
eq. to elemental Calcium |
|
500mg |
|
|
Vitamin D3 |
IP |
200 IU |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Coral Calcium, Cholecalciferol |
Composition: Each film coated tablet contains: |
|
|
|
& Vitamin K2-7 Tablets |
Coral Calcium |
IP |
|
|
|
eq. to elemental Calcium |
|
500mg |
114 |
|
Cholecalciferol |
IP |
1000 IU |
|
|
Vitamin K2-7 |
|
50mcg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Thiocolchicoside Sustained |
Composition: Each uncoated (SR) tablet contains: |
|
|
115 |
Release Tablets |
Thiocolchicoside |
IP |
16mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Paracetamol Tablets IP |
Composition: Each uncoated tablet contains: |
|
|
116 |
|
Paracetamol |
IP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Diacerein & Aceclofenac Tablet |
Composition: Each film coated tablet contains: |
|
|
|
|
Diacerein |
IP |
50mg |
117 |
|
Aceclofenac |
IP |
100mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
|
|
|
|
Metformin HCl (ER) & |
Composition: Each film coated tablet contains: |
|
|
|
Saxagliptin Tablets |
Metformin Hydrochloride |
IP |
500mg |
118 |
|
(As extended release form) |
|
|
|
|
Saxagliptin Hydrochloride |
|
|
|
|
eq. to Saxagliptin |
|
5mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Rutoside Trihydrate, Bromelain, |
Composition: Each enteric coated tablet contains: |
|
|
|
Aceclofenac & Trypsin Tablets |
Rutoside Trihydrate |
BP |
100mg |
119 |
|
Bromelain |
IP |
90mg |
|
|
Aceclofenac |
IP |
100mg |
|
|
Trypsin |
IP |
48mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Ibuprofen & Chlorzoxazone Tab |
Composition: Each uncoated tablet contains: |
|
|
|
|
Ibuprofen |
IP |
400mg |
120 |
|
Chlorzoxazone |
USP |
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Moxifloxacin Tablets |
Composition: Each film coated tablet contains: |
|
|
|
|
Moxifloxacin Hydrochloride |
IP |
|
121 |
|
eq. to Moxifloxacin |
|
400mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metoprolol Succinate Prolonged |
Composition: Each uncoated (PR) tablet contains |
|
|
122 |
Release Tablets IP |
Metoprolol Succinate |
IP |
25mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Tofacitinib Tablets IP |
Composition: Each film coated tablet contains: |
|
|
|
|
Tofacitinib Citrate |
IP |
|
123 |
|
eq. to Tofacitinib |
|
5mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Mefenamic acid & Dicyclomine |
Composition: Each uncoated tablet contains |
|
|
|
Hydrochloride Tablets IP |
Mefenamic acid |
IP |
250mg |
124 |
|
Dicyclomine Hydrochloride |
IP |
20mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Azithromycin & Ambroxol HCl |
Composition: Each film coated tablet contains: |
|
|
|
(SR) Tablets |
Azithromycin Dihydrate |
IP |
|
|
|
eq. to Azithromycin |
|
500mg |
125 |
|
Ambroxol Hydrochloride |
IP |
75mg |
|
|
(As Sustained Release form) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Pyridoxine Hydrochloride (CR) |
Composition: Each uncoated (CR) tablet contains |
|
|
|
Tablets |
Pyridoxine Hydrochloride |
IP |
100mg |
126 |
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Oral (Rehydration salt) Tablets |
Composition: Each uncoated tablet contains |
|
|
|
|
Sodium Chloride |
IP |
0.125gm |
|
|
Potassium Chloride |
IP |
0.150gm |
127 |
|
Sodium Bicarbonate |
IP |
0.250gm |
|
|
Citric acid (Anhydrous) |
IP |
0.577gm |
|
|
Dextrose (Anhydrous) |
IP |
2.650gm |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Telmisartan & Amlodipine |
Composition: Each uncoated tablet contains |
|
|
|
Tablets IP |
Telmisartan |
IP |
40mg |
128 |
|
Amlodipine Besylate |
IP |
|
|
|
eq. to Amlodipine |
|
5mg |
|
|
Excipients |
|
q.s |
|
Vitamin D3 Chewable Tablets |
Each uncoated chewable tablet contains |
|
|
129 |
|
Vitamin D3 |
IP |
60000 IU |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
Metformin Hydrochloride (ER), |
Each uncoated bilayered tablet contains |
|
|
|
Glimepiride & Pioglitazone |
Metformin Hydrochloride |
IP |
500mg |
|
Tablets |
(As extended release form) |
|
|
130 |
|
Glimepiride |
IP |
1mg |
|
|
Pioglitazone Hydrochloride |
IP |
|
|
|
eq. to Pioglitazone |
|
15mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
LEVOCETIRIZINE HYDROCHLORIDE |
IP |
5MG |
131 |
LEVOCETIRIZINE HCI & AMBROXOL |
Ambroxol Hydrochloride |
IP |
60MG |
|
HCI TABLETS |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Gabapentin |
IP |
100mg |
132 |
Gabapentin & Methylcobalamin |
Methylcobalamin |
IP |
500mcg |
|
TABLETS |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Sildenafil Citrate |
IP |
100mg |
133 |
Sildenafil Citrate Tablets IP |
eq. to Sildenafil |
|
q.s |
|
|
Excipients |
|
|
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Sildenafil Citrate |
IP |
50mg |
134 |
Sildenafil Citrate Tablets IP |
eq. to Sildenafil |
|
q.s |
|
|
Excipients |
|
|
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Sildenafil Citrate |
IP |
|
135 |
Sildenafil Citrate Dapoxetine |
eq. to Sildenafil |
|
50mg |
|
Tablets |
Dapoxetine Hydrochloride |
IP |
|
|
|
eq. to Dapoxetine |
|
30mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Sildenafil Citrate |
IP |
|
136 |
Sildenafil Citrate Dapoxetine |
eq. to Sildenafil |
|
100mg |
|
Tablets |
Dapoxetine Hydrochloride |
IP |
|
|
|
eq. to Dapoxetine |
|
60mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Pyridoxin Hydrochloride |
IP |
3mg |
|
Methylcobalamin Pyridoxin Hcl. |
Methylcobalamin |
IP |
1500mcg |
137 |
Vitamin D3 Folic acid & Alpha |
Alpha Lipoic Acid |
IP |
100mg |
|
Lipoic Acid Tablets |
Vitamin D3 |
IP |
1000 iu |
|
|
Folic acid |
IP |
1.5mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated tablet contains |
|
|
|
|
Torsemide |
IP |
10mg |
138 |
Torsemide Tablets IP |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated (MD) tablet contains |
|
|
|
|
Lansoprazole |
IP |
15mg |
139 |
Lansoprazole Mouth Dissolving |
Excipients |
|
q.s |
|
Tablets |
Colour: Approved colour used |
|
|
|
|
Each uncoated bilayered tablet contains |
|
|
|
Doxofylline (sr) & Montelukast |
Doxofylline |
IP |
|
|
Tablets |
(As Sustained Release form) |
|
400mg |
140 |
|
Montelukast sodium |
IP |
|
|
|
eq. to Montelukast |
|
10mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Tadalafi |
IP |
20mg |
141 |
Tadalafil & Dapoxetine |
eq. to Dapoxetine |
IP |
30mg |
|
Tablets |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Hydralazine Hydrochloride |
IP |
25mg |
142 |
Hydralazine Hydrochloride |
Excipients |
|
q.s |
|
Tablets usp |
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Tadalafil |
IP |
20MG |
143 |
Tadalafil tablets IP |
Excipients |
|
q.s |
|
|
|
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Paracetamol |
IP |
650MG |
144 |
Paracetamol Tablets IP |
Excipients |
|
q.s |
|
|
|
|
|
|
|
Each uncoated tablet contains |
|
|
|
|
Amlodipine |
IP |
|
145 |
Amlodipine & Indapamide (SR) |
eq. to Amlodipine |
|
10mg |
|
Tablets |
Indapamide |
IP |
1.5mg |
|
|
(As sustatned release form) |
|
q.s |
|
|
Excipients |
|
|
|
|
Each enteric coated tablet contains |
|
|
|
Pancreatin,Bile Constituents |
Pancreatin |
IP |
192mg |
146 |
& Activated Dimethicone Tablets |
Bile Constituents |
|
25mg |
|
|
Activated Dimethicone |
IP |
40mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated bilayered tablet contains |
|
|
|
|
Mefenamic acid |
IP |
250mg |
147 |
Mefenamic acid & Dicyclomine |
Dicyclomine Hydrochloride |
IP |
10mg |
|
Hydrochloride Tablets IP |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each enteric coated tablet contains |
|
|
|
|
Ademetionine 1.4-butane disulfonate (SD4) |
IP |
400mg |
148 |
Ademetionine Tablets |
eq. to Amlodipine Ione |
|
q.s |
|
|
Excipients |
|
|
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated tablet contains |
|
|
|
|
Cinnarizine |
IP |
20mg |
149 |
Cinnarizine & Dimenhydrinate |
Dimenhydrinate |
BP |
40mg |
|
Tablets |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated (SR) tablet contains |
|
|
|
|
Cinnarizine |
IP |
75mg |
150 |
Cinnarizine (SR) Tablets |
(As sustatned release form) |
|
|
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Levofloxacin Hemihydrate |
IP |
|
151 |
Levofloxacin tablets IP |
eq. to Levofloxacin |
|
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Clopidogrel Bisulphate |
IP |
|
152 |
Clopidogrel tablets IP |
eq. to Clopidogrel |
|
75mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated tablet contains |
|
|
|
|
Cyproheptadine Hydrochloride |
IP |
|
153 |
Cyproheptadine Tablets IP |
eq. to Cyproheptadine HCL (Anhydrous) |
|
4mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each Gastro-Resistant tablet contains |
|
|
|
Diclofenac Sodium Gastro-Resistant |
Diclofenac Sodium |
IP |
50mg |
154 |
Tablets IP |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated tablet contains |
|
|
|
|
Dexamethasone |
IP |
4mg |
155 |
Dexamethasone Tablets |
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each Prolonged-Release tablet contains |
|
|
|
|
Divalproex Sodium |
IP |
|
156 |
Divalproex (PR) Tablets IP |
eq. to Divalproex |
|
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each uncoated (MD) tablet contains |
|
|
|
|
Dexamethasone |
IP |
15MG |
157 |
Lansoprazole Orally (MD) |
Excipients |
|
q.s |
|
Disintegrating Tablets |
Colour: Approved colour used |
|
|
|
|
Each uncoated tablet contains |
|
|
|
|
Doxofylline |
IP |
400MG |
158 |
Doxofylline Tablets IP |
Excipients |
|
q.s |
|
|
|
|
|
|
|
Each Gastro-Resistant tablet contains |
|
|
|
|
Divalproex Sodium |
IP |
|
159 |
Divalproex (GR) Tablets IP |
eq. to Divalproex |
|
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Dried Ferrous Sulphate |
IP |
200mg |
160 |
Ferrous Sulphate Tablets IP |
eq. to elemental Iron |
|
60mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Aspirin |
IP |
400mg |
161 |
Aspirin & Caffeine Tablets IP |
Caffeine (Anhydrous) |
|
30mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Dapoxetine |
IP |
|
162 |
Dapoxetine Tablets IP |
eq. to Dapoxetine |
|
30mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|
|
|
Each film coated tablet contains |
|
|
|
|
Citicoline |
IP |
|
163 |
Citicoline Tablets IP |
eq. to Citicoline |
|
500mg |
|
|
Excipients |
|
q.s |
|
|
Colour: Approved colour used |
|
|